Current News & Events
Signature of a Second Grant Agreement for Financing medical treatment of the Syrian Refugees from cancer in the Hashemite Kingdom of Jordan
A Second Grant Agreement was signed today in Kuwait, between the King Hussein Cancer Center in Hashemite Kingdom of Jordan and Kuwait Fund for Arab Economic Development, whereby the Kuwait Fund will provide a Second Grant in the amount of US$ 1 million to further assist in financing the medical treatment of the Syrian Refugees from cancer in Hashemite Kingdom of Jordan, within the framework of the humanitarian support to the Syrian Refugees.
The Grant Agreement was signed on behalf of King Hussein Cancer Center in Hashemite Kingdom of Jordan by Her Royal Highness Princess Ghida Talal, Chairperson of the Board of Trustees of the Institution and Center of King Hussain for the Treatment of Cancer. The Agreement was signed on behalf of Kuwait Fund for Arab Economic Development by Mr. Abdulwahab Ahmed Al-Bader, Director-General of the Fund. His Excellency Mr. Mohammad Al-Kayed, Ambassador of the Hashemite Kingdom of Jordan to the State of Kuwait attended the ceremony of signature.
The grant aims at assisting in financing medical treatment costs of the Syrian refugees within the framework of the humanitarian support to the Syrian Refugees in the Hashemite Kingdom of Jordan through:
- Diagnosis of cancer patients through lab tests, radiological images, performing biopsies and analyses of biopsies.
- Treatment with chemotherapy, radiotherapy, physical treatment, medicines and bone marrow transplant.
- Surgery to eradicate tumors of any surgery related with the cancer treatment.
- Treatment of complications arising from cancer treatment.
- Medical procedures to relieve pain.
- Palliative treatment.
- Emergency services.
The services to be financed from the Grant will be available on exclusive basis to Syrian refugees (or those falling within the category of refugees) in Jordan suffering from cancer and seeking treatment at King Hussein Center for the Treatment of cancer.